Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 22, 2005
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International...
|
0
|
—
|
—
|
—
|
0
|
Feb 17
| |||||||
Charles River Laboratories International...
| -12.00K |
$46.77 | -$561,289.20 | -50.55% | 11.74K |
Nov 8
| |||||||
Charles River Laboratories International...
|
0
|
$37.07 | -$143,112.00 |
—
|
0
|
Nov 4
| |||||||
Inveresk Research Group Inc
| -49.46K |
—
|
—
| -100.00% |
0
|
Oct 20
| |||||||
Charles River Laboratories International...
| 23.74K |
—
|
—
|
∞
| 23.74K |
Oct 20
| |||||||
Charles River Laboratories International...
|
0
|
—
|
—
|
—
|
0
| ||||||||
Biomarin Pharmaceutical Inc
|
0
|
—
|
—
|
—
|
0
|
Jul 28
| |||||||
Inveresk Research Group Inc
| -30.00K |
$28.98 | -$869,319.00 | -37.76% | 49.46K |
May 13
| |||||||
Inveresk Research Group Inc
|
0
|
—
|
—
|
—
|
0
|
May 4
| |||||||
Inveresk Research Group Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 28
| |||||||
Inveresk Research Group Inc
| -11.00K |
$28.42 | -$312,587.00 | -12.16% | 79.46K |
Feb 20
| |||||||
Inveresk Research Group Inc
| -11.00K |
$19.20 | -$211,200.00 | -10.84% | 90.46K |
Nov 25
| |||||||
Inveresk Research Group Inc
| -9.00K |
$16.96 | -$152,640.00 | -8.15% | 101.46K |
Aug 12 - Aug 14
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Biomarin Pharmaceutical Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Biomarin Pharmaceutical Inc
|
0
|
—
|
—
|
—
|
0
|
Jul 28
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||